Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating or preventing clinical signs caused by infectious bronchitis virus with 4/91 IBV vaccine having heterologous spike protein

Method of treating or preventing clinical signs caused by infectious bronchitis virus with 4/91 IBV vaccine having heterologous spike protein

US Patent 11744888 · Granted Sep 5, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Attenuated IBV with extended cell culture and tissue tropism2025
Modified S1 subunit of the coronavirus spike protein2024
Modified S1 subunit of the coronavirus spike protein2024
H52 IBV vaccine with heterologous spike protein2023
H52 IBV vaccine with heterologous spike protein2023
Modified S1 subunit of the coronavirus spike protein2022
Modified S1 subunit of the coronavirus spike protein2022
4/91 IBV vaccine with heterologous spike protein2022
4/91 IBV vaccine with heterologous spike protein2022